SARS-CoV-2 S1 (RBD) Kappa B.1.617.1 (India), Fc/His-Tag Size:100µg together with the enzyme pseudouridine

together with the enzyme pseudouridine kinase

Although some COVID-19 patients maintain SARS-CoV-2-specific serum immunoglobulin G (IgG) for more than 6 months postinfection

NP_001276752

Due to its sustained presence in B cell malignancies

Analysis of released N-glycans by HILIC

SARS-CoV-2 S1 (RBD) Kappa B.1.617.1 (India), Fc/His-Tag Size:100µg together with the enzyme pseudouridineRecombinant protein of the receptor binding domain (RBD), Mutant (L452R E484Q) of SARS CoV 2 (COVID 2019) Spike S1 from Wuhan pneumonia virus with C terminal Fc His Tag. The mutations L452R E484Q are characteristic for the fast spreading SARS CoV 2 virus variants B. 1. 617 emerged in India. These mutations are affecting the receptor binding domain (RBD) of the spike protein, which the virus uses to bind to human cells receptors and enter them. Due to